Takeshi Asano

3.1k total citations
146 papers, 2.4k citations indexed

About

Takeshi Asano is a scholar working on Neurology, Surgery and Molecular Biology. According to data from OpenAlex, Takeshi Asano has authored 146 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Neurology, 33 papers in Surgery and 26 papers in Molecular Biology. Recurrent topics in Takeshi Asano's work include Intracranial Aneurysms: Treatment and Complications (25 papers), Vascular Malformations Diagnosis and Treatment (22 papers) and Cerebrovascular and Carotid Artery Diseases (9 papers). Takeshi Asano is often cited by papers focused on Intracranial Aneurysms: Treatment and Complications (25 papers), Vascular Malformations Diagnosis and Treatment (22 papers) and Cerebrovascular and Carotid Artery Diseases (9 papers). Takeshi Asano collaborates with scholars based in Japan, United States and Canada. Takeshi Asano's co-authors include Satoshi Ushikoshi, Mikihiro Fujioka, Yuko Yamaguchi‐Iwai, Fuyuki Ishikawa, Kazuhiro Iwaï, Noboru Mizushima, Masaaki Komatsu, Yoshio Hirota, Takashi Tanaka and Hoyoku Nishino and has published in prestigious journals such as Nature Communications, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Takeshi Asano

136 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takeshi Asano Japan 28 525 517 475 459 418 146 2.4k
Graham Wells United Kingdom 20 393 0.7× 806 1.6× 618 1.3× 198 0.4× 221 0.5× 26 2.9k
Abba C. Zubair United States 27 538 1.0× 601 1.2× 287 0.6× 280 0.6× 144 0.3× 94 2.5k
Michael J. Warhol United States 27 314 0.6× 455 0.9× 359 0.8× 112 0.2× 519 1.2× 70 2.0k
Lawrence M. Silverman United States 28 894 1.7× 917 1.8× 586 1.2× 190 0.4× 1.2k 2.8× 97 3.6k
Børge Teisner Denmark 29 384 0.7× 997 1.9× 284 0.6× 101 0.2× 256 0.6× 63 2.4k
Ilaria Bellantuono United Kingdom 28 1.1k 2.1× 1.7k 3.2× 768 1.6× 185 0.4× 255 0.6× 64 4.7k
Anne Plonquet France 25 430 0.8× 1.1k 2.2× 571 1.2× 281 0.6× 157 0.4× 40 3.1k
Stefania Rizzo Italy 31 769 1.5× 504 1.0× 252 0.5× 244 0.5× 256 0.6× 181 4.0k
Sakamuri V. Reddy United States 32 448 0.9× 1.3k 2.5× 1.0k 2.2× 121 0.3× 153 0.4× 58 2.9k
Scott D. Olson United States 29 1.3k 2.5× 2.7k 5.1× 563 1.2× 379 0.8× 396 0.9× 79 5.4k

Countries citing papers authored by Takeshi Asano

Since Specialization
Citations

This map shows the geographic impact of Takeshi Asano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Asano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Asano more than expected).

Fields of papers citing papers by Takeshi Asano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeshi Asano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Asano. The network helps show where Takeshi Asano may publish in the future.

Co-authorship network of co-authors of Takeshi Asano

This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Asano. A scholar is included among the top collaborators of Takeshi Asano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Asano. Takeshi Asano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asano, Takeshi, Akira Morimoto, Atsuko Nakazawa, et al.. (2025). Retrospective nationwide survey of pediatric RDD in Japan: a high prevalence of mutations in the kinase pathway genes. International Journal of Hematology. 122(1). 128–137. 1 indexed citations
2.
Asano, Takeshi, Akihiro Iguchi, & Taku Miyasho. (2020). Interleukin-6–Mediated Inflammation May Cause Methotrexate-Induced Leukoencephalopathy. Journal of Interferon & Cytokine Research. 40(7). 341–348. 2 indexed citations
3.
Maeda, Miho, Akira Morimoto, Yoko Shioda, et al.. (2020). Long‐term outcomes of children with extracutaneous juvenile xanthogranulomas in Japan. Pediatric Blood & Cancer. 67(7). e28381–e28381. 12 indexed citations
4.
Asano, Takeshi, et al.. (2012). [Subclavian artery stenting using gadolinium contrast medium in a case with iodine allergy].. PubMed. 40(5). 415–20. 2 indexed citations
5.
Narazaki, Hidehiko, et al.. (2012). Delayed-type Hypersensitivity in Response to L-asparaginase in a Case of Acute Lymphoblastic Leukemia. Journal of Nippon Medical School. 79(6). 489–493. 3 indexed citations
6.
Asano, Takeshi, Shinya Koizumi, Kunihiro Mashiko, et al.. (2011). High Mobility Group Box 1 in Cerebrospinal Fluid From Several Neurological Diseases at Early Time Points. International Journal of Neuroscience. 121(8). 480–484. 13 indexed citations
7.
Mabuchi, Shoji, et al.. (2011). Shunt-related Stenosis of Distal Cervical Internal Carotid Artery after Carotid Endarterectomy: Two Case Reports. Surgery for Cerebral Stroke. 39(1). 54–57. 1 indexed citations
8.
Asano, Takeshi, et al.. (2009). Concomitant Severe Normocytic and Normochromic Anemia in Poststreptococcal Acute Glomerulonephritis. Journal of Nippon Medical School. 76(5). 272–274.
9.
Homma, Akihiro, Yasushi Furuta, Fumiyuki Suzuki, et al.. (2007). Efficacy of superselective infusion of cisplatin and radiotherapy to control neck disease in head and neck cancers. Toukeibu Gan. 33(1). 39–42. 9 indexed citations
10.
Homma, Akihiro, Yasushi Furuta, Fumiyuki Suzuki, et al.. (2006). SUPERSELECTIVE ARTERIAL INFUSION AND CONCOMITANT RADIOTHERAPY FOR ADVANCED HEAD AND NECK CANCER. Toukeibu Gan. 32(1). 87–92. 6 indexed citations
11.
Asano, Takeshi, et al.. (2005). Indomethacin overcomes doxorubicin resistance with inhibiting multi-drug resistance protein 1 (MRP1). Cancer Chemotherapy and Pharmacology. 58(3). 348–353. 31 indexed citations
13.
Asano, Takeshi, Eugenie S. Kleinerman, Leonard A. Zwelling, Zhichao Zhou, & Yoshitaka Fukunaga. (2005). Adenovirus-mediated human topoisomerase IIα gene transfer increases the sensitivity of etoposide-resistant human and mouse breast cancer cells. Acta Oncologica. 44(3). 240–247. 11 indexed citations
14.
Shichinohe, Hideo, Satoshi Kuroda, Takeshi Asano, et al.. (2005). [Novel stent/CEA strategy for patients with bilateral carotid artery stenosis and coronary artery disease: report of 2 cases].. PubMed. 33(2). 149–53. 4 indexed citations
15.
Asano, Takeshi, et al.. (2003). Analysis of Resistance-Related Gene Expression in Doxorubicin-Resistant Leukemia Cell Line by DNA Microarray. 17(5). 340–345. 2 indexed citations
16.
Ushikoshi, Satoshi, Kiyohiro Houkin, Satoshi Kuroda, et al.. (2002). Surgical treatment of intracranial dural arteriovenous fistulas. Surgical Neurology. 57(4). 253–261. 29 indexed citations
17.
Oka, Eiji, Shigeru Sanada, Takeshi Asano, & Tomoko Ishida. (1997). Mental deterioration in childhood epilepsy.. PubMed. 51(4). 173–8. 3 indexed citations
18.
Asano, Takeshi, et al.. (1996). Effect of transfection of a Drosophila topoisomerase II gene into a human brain tumour cell line intrinsically resistant to etoposide. British Journal of Cancer. 73(11). 1373–1380. 16 indexed citations
19.
Asano, Takeshi, et al.. (1996). Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide.. PubMed. 8(3). 101–10. 13 indexed citations
20.
Suzuki, Takayoshi, Norio Kimura, Hiroyuki Suzuki, et al.. (1995). A CASE OF ACHALASIA COMPLICATED BY ESOPHAGEAL ULCER. Acta gastro-enterologica belgica. 37(3). 581–587.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026